All lobbying filings

TIBER CREEK GROUP

Lobbying for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF GENENTECH, INC.) · Government relations.

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 19, 2025

Income

$60,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

S 1041
Affordable Prescriptions for Patients Act
S 1096
Preserve Access to Affordable Generics and Biosimilars Act

Lobbying activity 3

Medicare/Medicaid

Issues related to Medicare Part B Pricing Reform.

Health Issues

Issues related to the 340B Program - Public Health Service Act (P.L. 78-410).

Issues related to intellectual property; Issues related to S.1041 - Affordable Prescriptions for Patients Act; Issues related to patent thickets; Issues related to S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.